{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:29Z","timestamp":1787959889048,"version":"build-2784847793"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Comorbidities are frequent in heart failure and impact outcomes. It is not known whether comorbidities are associated with outcomes in asymptomatic left ventricular dysfunction compared to clinical heart failure and whether comorbidities interfere with treatment effects. Our objective was to assess comorbidities and their effects on outcomes in predominantly asymptomatic populations without previous heart failure treatment of the SOLVD prevention trial, compared to symptomatic heart failure patients of SOLVD treatment and to evaluate associations to the effect of enalapril.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This post hoc analysis from the SOLVD prevention and SOLVD treatment trials includes 4228 patients with left ventricular dysfunction and 2569 patients with heart failure. The preexisting comorbidities hypertension, diabetes mellitus, pulmonary disease, angina pectoris, renal impairment, and anaemia were similar in SOLVD treatment and SOLVD prevention, with a higher prevalence in SOLVD treatment. Comorbidities are significantly associated with the primary composite of SOLVD time to death or heart failure hospitalization (SOLVD prevention: HR 4.8, CI: 3.2\u20137.18, P\u2009&amp;lt;\u20090.0001; SOLVD treatment: HR 2.9, CI: 2.12\u20133.95, P\u2009&amp;lt;\u20090.0001 for more than four comorbidities vs. no comorbidities), and to death, heart failure hospitalization, and cardiovascular death where the effect of the number of coexisting comorbidities was additive. There was no significant interaction of comorbidities with treatment effects of enalapril.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Comorbidities increased events in asymptomatic left ventricular dysfunction and in symptomatic heart failure, but did not interfere with the effects of enalapril. Comorbidities need to be adequately addressed in clinical trials, which should also involve non-cardiac treatments in order to improve outcome for heart failure patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.23","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T12:29:04Z","timestamp":1390480144000},"page":"325-333","source":"Crossref","is-referenced-by-count":18,"title":["Effect of Comorbidities on Outcomes and Angiotensin Converting Enzyme Inhibitor Effects in Patients with Predominantly Left Ventricular Dysfunction and Heart Failure"],"prefix":"10.1093","volume":"16","author":[{"given":"Michael","family":"B\u00f6hm","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes , DE-66424, Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Pogue","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, Ontario, L8L 2X2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kindermann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes , DE-66424, Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"P\u00f6ss","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin III, Universit\u00e4tsklinikum des Saarlandes , DE-66424, Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teo","family":"Koon","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, Ontario, L8L 2X2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, McMaster University , Hamilton, Ontario, L8L 2X2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,23]]},"reference":[{"key":"2026011921111425900_ejhf23-bib-0001","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"2026011921111425900_ejhf23-bib-0003","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"key":"2026011921111425900_ejhf23-bib-0004","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1053\/euhj.1997.0859","article-title":"Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995","volume":"19","author":"Brown","year":"1998","journal-title":"Eur Heart J"},{"key":"2026011921111425900_ejhf23-bib-0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J Gen Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0006","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"key":"2026011921111425900_ejhf23-bib-0007","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011921111425900_ejhf23-bib-0008","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011921111425900_ejhf23-bib-0009","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(03)00789-7","article-title":"The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure","volume":"42","author":"Curtis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011921111425900_ejhf23-bib-0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0012","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921111425900_ejhf23-bib-0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation"},{"key":"2026011921111425900_ejhf23-bib-0014","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0017","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jacc.2009.08.019","article-title":"Hospitalizations after heart failure diagnosis a community perspective","volume":"54","author":"Dunlay","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011921111425900_ejhf23-bib-0018","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11886-012-0259-9","article-title":"The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient","volume":"14","author":"Page","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"2026011921111425900_ejhf23-bib-0019","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/archinte.161.19.2317","article-title":"Drug-related deaths in a department of internal medicine","volume":"161","author":"Ebbesen","year":"2001","journal-title":"Arch Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-75-1-1","article-title":"Precipitation of congestive heart failure: social and emotional factors","volume":"75","author":"Perlman","year":"1971","journal-title":"Ann Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0022","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1532-5415.1990.tb03450.x","article-title":"Early readmission of elderly patients with congestive heart failure","volume":"38","author":"Vinson","year":"1990","journal-title":"Am Geriatr Soc"},{"key":"2026011921111425900_ejhf23-bib-0023","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the elderly, women, and minorities in heart failure clinical trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0024","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mhj.2002.120773","article-title":"Spectrum of heart failure in older patients: results from the National Heart Failure project","volume":"143","author":"Havranek","year":"2002","journal-title":"Am Heart J"},{"key":"2026011921111425900_ejhf23-bib-0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1076-7460.2007.06211.x","article-title":"Heart failure in the \u201coldest old\u201d: clinical and echocardiographic insights","volume":"16","author":"Bouchard","year":"2007","journal-title":"Am J Geriatr Cardiol"},{"key":"2026011921111425900_ejhf23-bib-0026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/aje\/153.3.299","article-title":"Validity of self-reported cancer history: a comparison of health interview data and cancer registry records","volume":"153","author":"Desai","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2026011921111425900_ejhf23-bib-0027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.aje.a115129","article-title":"Agreement between questionnaire data and medical records. The evidence for accuracy of recall","volume":"129","author":"Harlow","year":"1989","journal-title":"Am J Epidemiol"},{"key":"2026011921111425900_ejhf23-bib-0028","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","article-title":"Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure","volume":"57","author":"Okura","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"2026011921111425900_ejhf23-bib-0029","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurjhf\/hfr116","article-title":"Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups","volume":"13","author":"Mogensen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921111425900_ejhf23-bib-0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011921111425900_ejhf23-bib-0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N Engl J Med"},{"key":"2026011921111425900_ejhf23-bib-0032","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archinte.166.10.1134","article-title":"Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease","volume":"166","author":"Smith","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026011921111425900_ejhf23-bib-0033","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.23","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/16\/3\/325\/66434848\/eurjhf_16_3_325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/16\/3\/325\/66434848\/eurjhf_16_3_325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:12:17Z","timestamp":1768875137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/16\/3\/325\/8427770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,23]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,1,23]]},"published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.23","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,1,23]]}}}